DAFNA Capital Management as of Dec. 31, 2016
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 66 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 8.9 | $10M | 519k | 19.57 | |
| NxStage Medical | 5.4 | $6.2M | 236k | 26.21 | |
| Alder Biopharmaceuticals | 4.0 | $4.6M | 221k | 20.80 | |
| Loxo Oncology | 3.9 | $4.5M | 140k | 32.11 | |
| Galapagos Nv- (GLPG) | 3.7 | $4.2M | 66k | 64.19 | |
| Sunesis Pharmaceuticals Inc Ne | 3.6 | $4.1M | 1.1M | 3.62 | |
| Xenon Pharmaceuticals (XENE) | 3.5 | $4.0M | 514k | 7.70 | |
| Aerie Pharmaceuticals | 3.3 | $3.7M | 98k | 37.85 | |
| Beigene (BGNE) | 3.2 | $3.6M | 120k | 30.36 | |
| Dermira | 2.6 | $3.0M | 99k | 30.33 | |
| Foamix Pharmaceuticals | 2.6 | $3.0M | 268k | 11.10 | |
| Insulet Corporation (PODD) | 2.4 | $2.8M | 74k | 37.68 | |
| Applied Genetic Technol Corp C | 2.4 | $2.7M | 286k | 9.35 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $2.6M | 66k | 38.71 | |
| Cytokinetics (CYTK) | 2.2 | $2.6M | 210k | 12.15 | |
| Ardelyx (ARDX) | 2.2 | $2.5M | 174k | 14.20 | |
| Insulet Corp note 2.000% 6/1 | 2.1 | $2.5M | 2.3M | 1.09 | |
| iShares NASDAQ Biotechnology Index (IBB) | 2.0 | $2.3M | 8.7k | 265.40 | |
| Tesaro | 1.8 | $2.1M | 16k | 134.45 | |
| Immunomedics | 1.8 | $2.1M | 560k | 3.67 | |
| Radius Health | 1.8 | $2.0M | 54k | 38.03 | |
| Blueprint Medicines (BPMC) | 1.8 | $2.0M | 73k | 28.06 | |
| Cara Therapeutics (CARA) | 1.7 | $1.9M | 210k | 9.29 | |
| Derma Sciences | 1.6 | $1.8M | 354k | 5.20 | |
| Macrogenics (MGNX) | 1.6 | $1.8M | 89k | 20.44 | |
| Biotelemetry | 1.5 | $1.7M | 75k | 22.35 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.5 | $1.7M | 160k | 10.40 | |
| Spectranetics Corporation | 1.4 | $1.6M | 66k | 24.51 | |
| Tandem Diabetes Care | 1.4 | $1.6M | 724k | 2.15 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.4 | $1.6M | 2.5M | 0.62 | |
| Aeglea Biotherapeutics | 1.3 | $1.5M | 350k | 4.35 | |
| Inotek Pharmaceuticals | 1.3 | $1.4M | 237k | 6.10 | |
| Advaxis | 1.1 | $1.3M | 175k | 7.16 | |
| Uniqure Nv (QURE) | 1.0 | $1.1M | 204k | 5.60 | |
| Johnson & Johnson (JNJ) | 0.9 | $1.1M | 9.4k | 115.21 | |
| Ascendis Pharma A S (ASND) | 0.9 | $1.1M | 53k | 20.25 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $1.0M | 46k | 21.98 | |
| Zogenix | 0.8 | $906k | 75k | 12.15 | |
| Stereotaxis (STXS) | 0.8 | $892k | 1.4M | 0.65 | |
| Exactech | 0.8 | $864k | 32k | 27.31 | |
| ArQule | 0.7 | $843k | 669k | 1.26 | |
| Neuroderm Ltd F | 0.7 | $842k | 38k | 22.20 | |
| Achillion Pharmaceuticals | 0.7 | $812k | 197k | 4.13 | |
| Syneron Medical Ltd ord | 0.6 | $722k | 86k | 8.40 | |
| Novadaq Technologies | 0.6 | $722k | 102k | 7.09 | |
| Cogentix Medical | 0.6 | $711k | 354k | 2.01 | |
| Concert Pharmaceuticals I equity | 0.6 | $689k | 67k | 10.29 | |
| Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.6 | $690k | 600k | 1.15 | |
| Masimo Corporation (MASI) | 0.6 | $674k | 10k | 67.40 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.5 | $618k | 600k | 1.03 | |
| Arbutus Biopharma (ABUS) | 0.5 | $573k | 234k | 2.45 | |
| Bluebird Bio (BLUE) | 0.5 | $555k | 9.0k | 61.67 | |
| Scynexis | 0.5 | $554k | 174k | 3.19 | |
| Eiger Biopharmaceuticals | 0.4 | $468k | 40k | 11.64 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $417k | 66k | 6.33 | |
| Abeona Therapeutics | 0.3 | $372k | 77k | 4.84 | |
| Pieris Pharmaceuticals | 0.3 | $315k | 223k | 1.41 | |
| Essa Pharma | 0.2 | $289k | 98k | 2.95 | |
| Celyad Sa | 0.2 | $222k | 13k | 17.72 | |
| Neos Therapeutics | 0.2 | $227k | 39k | 5.84 | |
| Spring Bk Pharmaceuticals In | 0.2 | $219k | 27k | 7.99 | |
| Synergy Pharmaceuticals | 0.2 | $207k | 34k | 6.09 | |
| Avinger | 0.1 | $93k | 25k | 3.72 | |
| Biopharmx | 0.0 | $29k | 77k | 0.38 | |
| Genvec | 0.0 | $31k | 9.6k | 3.24 | |
| Check Cap Ltd w exp 02/28/202 | 0.0 | $10k | 15k | 0.66 |
